164 related articles for article (PubMed ID: 15952102)
1. Susceptibility to thyroid disorders in hepatitis C.
Muratori L; Bogdanos DP; Muratori P; Lenzi M; Granito A; Ma Y; Mieli-Vergani G; Bianchi FB; Vergani D
Clin Gastroenterol Hepatol; 2005 Jun; 3(6):595-603. PubMed ID: 15952102
[TBL] [Abstract][Full Text] [Related]
2. Clinical impact of non-organ-specific autoantibodies on the response to combined antiviral treatment in patients with hepatitis C.
Muratori P; Muratori L; Guidi M; Granito A; Susca M; Lenzi M; Bianchi FB
Clin Infect Dis; 2005 Feb; 40(4):501-7. PubMed ID: 15712070
[TBL] [Abstract][Full Text] [Related]
3. Non-organ-specific autoantibodies in children with chronic hepatitis C: clinical significance and impact on interferon treatment.
Muratori P; Muratori L; Verucchi G; Attard L; Bianchi FB; Lenzi M
Clin Infect Dis; 2003 Nov; 37(10):1320-6. PubMed ID: 14583865
[TBL] [Abstract][Full Text] [Related]
4. Virologic factors related to interferon-alpha-induced thyroid dysfunction in patients with chronic hepatitis C.
Hsieh MC; Yu ML; Chuang WL; Shin SJ; Dai CY; Chen SC; Lin ZY; Hsieh MY; Liu JF; Wang LY; Chang WY
Eur J Endocrinol; 2000 May; 142(5):431-7. PubMed ID: 10802518
[TBL] [Abstract][Full Text] [Related]
5. Thyroid disorders and occurrence of nonorgan-specific autoantibodies (NOSA) in patients with chronic hepatitis C before and during antiviral induction therapy with consensus interferon (interferon alfacon-1).
Hass HG; Klein R; Nehls O; Kaiser S
J Clin Gastroenterol; 2009; 43(5):470-6. PubMed ID: 19247202
[TBL] [Abstract][Full Text] [Related]
6. Non-organ specific autoantibodies in children with chronic hepatitis C.
Bortolotti F; Vajro P; Balli F; Giacchino R; Crivellaro C; Barbera C; Cataleta M; Muratori L; Pontisso P; Nebbia G; Zancan L; Bertolini A; Alberti A; Bianchi F
J Hepatol; 1996 Nov; 25(5):614-20. PubMed ID: 8938535
[TBL] [Abstract][Full Text] [Related]
7. LKM1 autoantibodies in chronic hepatitis C infection: a case of molecular mimicry?
Marceau G; Lapierre P; Béland K; Soudeyns H; Alvarez F
Hepatology; 2005 Sep; 42(3):675-82. PubMed ID: 16037945
[TBL] [Abstract][Full Text] [Related]
8. Clinical features and effect of antiviral therapy on anti-liver/kidney microsomal antibody type 1 positive chronic hepatitis C.
Ferri S; Muratori L; Quarneti C; Muratori P; Menichella R; Pappas G; Granito A; Ballardini G; Bianchi FB; Lenzi M
J Hepatol; 2009 Jun; 50(6):1093-101. PubMed ID: 19398235
[TBL] [Abstract][Full Text] [Related]
9. Multiple viral/self immunological cross-reactivity in liver kidney microsomal antibody positive hepatitis C virus infected patients is associated with the possession of HLA B51.
Bogdanos DP; Lenzi M; Okamoto M; Rigopoulou EI; Muratori P; Ma Y; Muratori L; Tsantoulas D; Mieli- Vergani G; Bianchi FB; Vergani D
Int J Immunopathol Pharmacol; 2004; 17(1):83-92. PubMed ID: 15000871
[TBL] [Abstract][Full Text] [Related]
10. Sera of children with hepatitis C infection and anti-liver-kidney microsome-1 antibodies recognize different CYP2D6 epitopes than adults with LKM+/HCV+ sera.
Herzog D; Yamamoto AM; Jara P; Maggiore G; Sarles J; Alvarez F
J Pediatr Gastroenterol Nutr; 1999 Nov; 29(5):551-5. PubMed ID: 10554122
[TBL] [Abstract][Full Text] [Related]
11. A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: the role of interferon in the development of autoimmune diseases.
Bayraktar Y; Bayraktar M; Gurakar A; Hassanein TI; Van Thiel DH
Hepatogastroenterology; 1997; 44(14):417-25. PubMed ID: 9164512
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of non-organ-specific autoantibodies and chronic liver disease in the general population: a nested case-control study of the Dionysos cohort.
Lenzi M; Bellentani S; Saccoccio G; Muratori P; Masutti F; Muratori L; Cassani F; Bianchi FB; Tiribelli C
Gut; 1999 Sep; 45(3):435-41. PubMed ID: 10446115
[TBL] [Abstract][Full Text] [Related]
13. Interferon therapy in LKM-1 positive patients with chronic hepatitis C: follow-up by a quantitative radioligand assay for CYP2D6 antibody detection.
Duclos-Vallée JC; Nishioka M; Hosomi N; Arima K; Leclercq A; Bach JF; Yamamoto AM
J Hepatol; 1998 Jun; 28(6):965-70. PubMed ID: 9672171
[TBL] [Abstract][Full Text] [Related]
14. Autoimmunity against pancreatic islets and other tissues before and after interferon-alpha therapy in patients with hepatitis C virus chronic infection.
Betterle C; Fabris P; Zanchetta R; Pedini B; Tositti G; Bosi E; de Lalla F
Diabetes Care; 2000 Aug; 23(8):1177-81. PubMed ID: 10937518
[TBL] [Abstract][Full Text] [Related]
15. Do thyroid abnormalities detected in patients treated for HCV-related chronic hepatitis persist?
Tarantino G; Gagliardi G; Conca P
Int J Immunopathol Pharmacol; 2008; 21(2):467-9. PubMed ID: 18547494
[TBL] [Abstract][Full Text] [Related]
16. Organ-specific autoimmunity and genetic predisposition in interferon-treated HCV-related chronic hepatitis patients.
Floreani A; Chiaramonte M; Greggio NA; Fabris P; De Lazzari F; Naccarato R; Betterle C
Ital J Gastroenterol Hepatol; 1998 Feb; 30(1):71-6. PubMed ID: 9615270
[TBL] [Abstract][Full Text] [Related]
17. Interferon and prednisone therapy in chronic hepatitis C with non-organ-specific antibodies.
Calleja JL; Albillos A; Cacho G; Iborra J; Abreu L; Escartín P
J Hepatol; 1996 Mar; 24(3):308-12. PubMed ID: 8778197
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis C virus infection associated with liver-kidney microsomal antibody type 1 (LKM1) autoantibodies in children.
Bortolotti F; Muratori L; Jara P; Hierro L; Verucchi G; Giacchino R; Barbera C; Zancan L; Guido M; Resti M; Pedditzi S; Bianchi F; Gatta A
J Pediatr; 2003 Feb; 142(2):185-90. PubMed ID: 12584542
[TBL] [Abstract][Full Text] [Related]
19. Autoimmune and non-autoimmune thyroid dysfunction in HCV infected and HCV-HIV co-infected patients before and after interferon alpha therapy: A prospective study.
Lowenstein A; Fainboim H; Reyes A; Lutzky C; Ameigeiras B; Schroder T; Eugenio Russmann ML
Endocrinol Diabetes Nutr (Engl Ed); 2020 Apr; 67(4):263-271. PubMed ID: 31266712
[TBL] [Abstract][Full Text] [Related]
20. [Hepatitis C virus infection and thyroid diseases].
Broussolle C; Steineur MP; Bailly F; Zoulim F; Trépo C
Rev Med Interne; 1999 Sep; 20(9):766-73. PubMed ID: 10522298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]